Biogenes Technologies

Biogenes Technologies is a healthcare company in Putrajaya, Singapore, founded in 2020. It has raised $5.7M across 2 rounds, most recently a $5.7M Series A in January 2023.

Diagnostics Simplified

Headquarters
Putrajaya
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$5.7M
Last Round
$5.7M Series AJan 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Biogenes Technologies is a Malaysian biotechnology startup specializing in the design, development, and commercialization of animal-free aptamer-based biosensors for molecular diagnostics applications. The company's platform technologies include printed nano-coated sensors, aptamer immobilization, and in-silico aptamer design, enabling lower-cost and more stable diagnostic solutions compared to conventional antibody-based methods. Biogenes serves healthcare, animal breeding, agriculture, aquaculture, and food safety markets, and is expanding across Southeast Asia following its $5.7M Series A raise in 2023.

Summary

It lists 11–50 employees. It has raised $5.7M in total across 2 rounds, most recently a $5.7M Series A round in Jan 2023. Investors include Pembangunan Ekuiti and Antler.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJan 2023
$5.7M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biogenes Technologies on Indexed.vc
<a href="https://indexed.vc/companies/biogenes-technologies"><img src="https://indexed.vc/api/badge/company/biogenes-technologies" alt="Biogenes Technologies on Indexed.vc" width="260" height="76" /></a>